Welcome to the MassDevice Fast Five medtech news podcast, the show that keeps you up-to-date on the latest breakthroughs in medical technology. Here’s what you need to know for today, October 31, 2023.
Cardio Flow this week announced the first commercial cases using its Freedom Flow device and appointed a new chief operating officer. Fast Five hosts Sean Whooley and Danielle Kirsh discuss what the device does, as well as the new executive appointment and some of their career history.
Cognito Therapeutics appointed a new chief commercial officer this week. Whooley goes over the new appointee’s career history, their optimism upon joining the neuromod tech developer and what other executives think.
The FDA has cleared a non-invasive insomnia treatment device from Neurovalens. Find out what this device is, how it works and what executives think about the future of the device.
The FDA is also warning about some over-the-counter eye drops. Whooley and Kirsh talk about what the warning covers, what products are affected and what the FDA is recommending customers and businesses carrying the eye drops do.
A new report from the Pittsburgh Post Gazette and ProPublica said that Philips CEO Roy Jakobs approved the continued sale of defective sleep respiratory devices. Hear what the report claimed, what lawyers think and the statement given to Whooley from Philips about this report.
Follow the Fast Five hosts on LinkedIn
Subscribe to the Fast Five daily news podcast on your preferred listening platform. If you’re on a desktop computer, scan the QR code below with your smartphone to easily access the podcast on your mobile device.
Listen to previous episodes here.
